PhotoMedex Appoints Christina L. Allgeier Chief Financial Officer

MONTGOMERYVILLE, Pa.--(Business Wire)--
PhotoMedex, Inc. (Nasdaq: PHMD) today announced that Christina L. Allgeier has
been promoted to the post of Chief Financial Officer of PhotoMedex, Inc.,
effective November 4, 2009. Ms. Allgeier is a Certified Public Accountant with
significant SEC experience and joined the Company as Corporate Controller in
December 2002, when PhotoMedex acquired Surgical Laser Technologies.

PhotoMedex`s President and CEO, Dennis M. McGrath, commented, "Christina has
been a true asset to the management team. This appointment not only recognizes
Christina`s past contributions but, even more significantly, it expresses our
confidence in her ability to assist us in successfully navigating PhotoMedex
into a substantially larger, more diverse healthcare player."

About PhotoMedex

PhotoMedex develops proprietary excimer laser and fiber optic systems and
techniques directed toward dermatological applications, with FDA 510(k)
clearances to market the XTRAC® laser system for the treatment of psoriasis,
vitiligo, atopic dermatitis and leukoderma. The Company also develops and
markets products based on DNA Repair enzymes and its patented, clinically proven
Copper Peptide technology for skin health, hair care and wound care. PhotoMedex
sells directly to dermatologists, plastic and cosmetic surgeons, and salons.
ProCyte brands include Neova®, Ti-Silc®, VitalCopper®, Simple Solutions® and
AquaSanté®. PhotoMedex also develops, manufactures and markets medical laser
products and services.

In addition, as a result of the recent merger with PhotoTherapeutics, PhotoMedex
now researches, develops and manufactures non-laser light devices for the
treatment of clinical and aesthetic dermatological conditions and adds the
Omnilux products to its portfolio. The Omnilux products incorporate a new
technology based on narrowband Light Emitting Diodes (LEDs) to treat a wide
range of dermatological conditions including acne, photodamage, and skin
rejuvenation.

This press release includes forward-looking statements within the meaning of the
"safe harbor" provisions of the Private Securities Litigation Reform Act of
1995. These statements are based on management`s current expectations and
beliefs and are subject to a number of factors and uncertainties that could
cause actual results to differ materially from those described in the
forward-looking statements.

Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz (investors)
212-838-3777
Kgolodetz@lhai.com
Bruce Voss, 310-691-7100
Bvoss@lhai.com
or
PhotoMedex, Inc.
Dennis McGrath, CEO
215-619-3287
info@photomedex.com

Copyright Business Wire 2009